Posted inLondon Stock Exchange
Eli Lilly to acquire Centessa Pharmaceuticals for $6.3 billion
LONDON - Eli Lilly and Company has entered into a definitive agreement to acquire public portfolio company Centessa Pharmaceuticals plc. ("Centessa", Nasdaq: CNTA). Centessa is a clinical-stage biotech developing a…